Marí A E Fernández|Jennifer D. Allen|Ritesh Mistry|Jessica A. Kahn
Integrating Clinical, Community, and Policy Perspectives on Human Papillomavirus Vaccination
The University of Texas Health Science Center at Houston|Dana-Farber Cancer Institute|Harvard University|University of California, Los Angeles|Cincinnati Children's Hospital Medical Center|University of Cincinnati
infection genital human papillomavirus hpv may cause anogenital cancers oropharyngeal cancers anogenital warts respiratory papillomas two prophylactic vaccines bivalent quadrivalent vaccine licensed currently use number countries vaccines prevent infection hpv16 hpv18 together cause 70 cervical cancers clinical trials demonstrated 90100 efficacy preventing precancerous cervical lesions attributable hpv16 hpv18 one vaccine also prevents hpv6 hpv11 cause 90 genital warts growing literature describes psychosocial interpersonal organizational societal factors influence hpv vaccination acceptability review summarizes current literature presents integrated perspective taking account diverse influences resulting integrated framework used heuristic tool organizing factors multiple levels guide intervention development future research